Michael Seth Altman - Jun 30, 2023 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Michael Seth Altman
Stock symbol
LYRA
Transactions as of
Jun 30, 2023
Transactions value $
$0
Form type
4
Date filed
7/5/2023, 09:49 PM
Previous filing
Jun 20, 2023
Next filing
Jun 11, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable on June 30, 2024, subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date.